Systasy Bioscience GmbH
Systasy Bioscience GmbH is a technology provider specializing in hyper-multiplexed drug discovery solutions for complex diseases, particularly those affecting the brain. They leverage proprietary DNA barcoding technology for highly multiplexed transcriptomic analysis at the single-cell level. Their platform supports target identification, combinatorial drug screening, and patient stratification through AI-driven insights, pathway activity screens, and patient-derived human disease models. Systasy aims to accelerate the development of effective treatments by improving the understanding of disease mechanisms and increasing success rates in drug discovery.
Systasy Bioscience GmbH
Systasy Bioscience GmbH is a technology provider specializing in hyper-multiplexed drug discovery solutions for complex diseases, particularly those affecting the brain. They leverage proprietary DNA barcoding technology for highly multiplexed transcriptomic analysis at the single-cell level. Their platform supports target identification, combinatorial drug screening, and patient stratification through AI-driven insights, pathway activity screens, and patient-derived human disease models. Systasy aims to accelerate the development of effective treatments by improving the understanding of disease mechanisms and increasing success rates in drug discovery.